Venice Regional Bayfront Health Center for Wound Care Earns National Award for Continued Excellence in Wound Healing
For the eighth consecutive year, Venice Regional Bayfront Health Center for Wound Care has earned a prestigious national award for continued excellence in wound healing. The Robert A. Warriner, III Center of Excellence Award recognizes Wound Care Centers® in the Healogics network that have met the highest level of quality standards for a minimum of two consecutive years.
The Venice Regional Center for Wound Care achieved patient satisfaction rates higher than 92 percent and a healing rate of at least 91 percent in less than 31 median days, along with several other quality standards, on a continuing basis. Across the country, 169 wound care centers out of 334 that were eligible achieved this distinction in 2017.
“Venice Regional is focused on providing the highest levels of quality care to patients. Wound care is one of the most challenging aspects of patient care. This award is a testament to the daily dedication and commitment of team members at the Venice Regional Center for Wound Care and the hospital medical staff,” said John McLain, Venice Regional chief executive officer.
The award is named for Dr. Warriner, a pioneer in wound care and the former chief medical officer for Healogics, the nation’s leading and largest wound care management company. The Healogics network of nearly 800 wound care centers gives Venice Regional’s center access to benchmarking data and proven experience treating approximately 2.5 million chronic wounds.
The Venice Regional Center for Wound Care provides in-patient care at the hospital and out-patient care at Venice HealthPark, 1201 Jacaranda Boulevard. The Center for Wound Care offers highly specialized wound care to patients suffering from diabetic ulcers, pressure ulcers, infections and other chronic wounds that have not healed in a reasonable amount of time. Some of the advanced treatments offered by the center include negative pressure wound therapy, debridement, application of cellular-based tissue or skin substitutes to the wound, offloading or total contact casts and hyperbaric oxygen therapy.